focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,110.00
Bid: 1,114.00
Ask: 1,122.00
Change: -50.00 (-4.31%)
Spread: 8.00 (0.718%)
Open: 1,186.00
High: 1,186.00
Low: 1,110.00
Prev. Close: 1,160.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Apr 2019 15:24

RNS Number : 3783W
Savills PLC
16 April 2019
 

SAVILLS PLC (THE 'COMPANY')

NOTIFICATION OF INTERESTS OF DIRECTORS/ PDMRS

 

Grant of Share Awards

 

The Company announces that on 15 April 2019 the grant of the share based element of 2018 profit share awards has been made under the Savills Deferred Share Bonus Plan to Directors and other persons discharging managerial responsibilities ('PDMR') as follows:-

 

Director/ PDMR

Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the Director / PDMR on15 April 2019

Resulting beneficial interest under the Savills Deferred Share Bonus Plan and Savills Deferred Share Plan

Mark Ridley (Director)

39,673

134,119

Simon Shaw (Director)

59,182

158,540

Simon Hope (PDMR)

5,449

19,587

Chris Lee (PDMR)

12,643

37,008

Christian Mancini (PDMR)

9,940

26,403

James Sparrow (PDMR)

26,594

44,375

 

The Company announces that on 15 April 2019 the grant of the share based element of 2018 profit share awards has been made under The Schedule to The Savills Deferred Share Bonus Plan to PDMRs based in the United States of America as follows:-

 

PDMR

Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the PDMR on15 April 2019

Resulting beneficial interest under the Savills Deferred Share Bonus Plan

Mitchell Steir (PDMR)

17,190

34,588

All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

The Company announces that on 15 April 2019 awards have been made under The Savills plc Performance Share Plan (the 'Performance Share Plan') to Directors and PDMRS as follows:- 

 

Director/ PDMR

Number of shares subject to the Performance Share Plan awarded to the Director / PDMR on 15 April 2019

Total number of shares subject to Performance Share Plan Awards following this notification

Mark Ridley (Director)

62,997

161,579

Simon Shaw (Director)

48,174

149,835

Chris Lee (PDMR)

24,523

65,708

The Performance Share Plan provides for the award of nil cost options or conditional awards of ordinary shares in the Company.

Awards of shares are made subject to a three-year performance period. Awards which satisfy the applicable performance criteria (as below) in the three-year performance period will then vest after an additional two-year holding period for Directors.

Awards vest subject to the satisfaction of the following performance criteria measured over the three years following grant:

(a) 50% of the initial value of an award is subject to the Company's Total Shareholder Return ('TSR') performance measured against the TSR of the FTSE Mid 250 Index (excluding investment trusts);

(b) the other 50% of the initial value of an award is subject to real (i.e. growth in excess of RPI) Group Earnings per Share ('EPS') growth performance.

Awards vest as follows:

(a) for the TSR linked part of an award, 25% (i.e. threshold) will vest if the Company's TSR matches Index performance, rising to 100% (i.e. maximum) if the Company's TSR outperforms the Index by 8% p.a., compound with sliding scale vesting between the two points; and

(b) for the EPS growth linked part of an award, 25% (i.e. threshold) will vest if the Company's real EPS growth (i.e. growth in excess of RPI) is 3% p.a., compound rising to 100% (i.e. maximum) if the Company's real (i.e. growth in excess of RPI) EPS growth is 8% p.a., compound with sliding scale vesting between the two points.

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the person discharging managerial responsibilities/ person closely associated

 

(a)

Name

1. Mark Ridley

2. Simon Shaw

3. Simon Hope

4. Chris Lee

5. Christian Mancini

6. James Sparrow

7. Mitchell Steir

 

2.

Reason for the notification

 

(a)

Position/ status

1. Group Chief Executive/ Director

2. Group Chief Financial Officer/ Director

3. Global Head of Capital Markets/ PDMR

4. Group Legal Director and Company Secretary/ PDMR

5. Chief Executive Officer Asia Pacific (ex-Greater China) / PDMR

6. Chief Executive Officer UK & EMEA/ PDMR

7. Chairman and CEO - Savills North America/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Bonus Plan ('DSBP') and Performance Share Plan ('PSP')

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£nil per share

 

1. 39,673 (DSBP) & 62,997 (PSP)

2. 59,182 (DSBP) & 48,174 (PSP)

3. 5,449 (DSBP)

4. 12,643 (DSBP) & 24,523 (PSP)

5. 9,940 (DSBP)

6. 26,594 (DSBP)

7. 17,190 (DSBP)

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

15 April 2019

(g)

Place of the transaction

 

Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

16 April 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKMGMDMVMGLZM
Date   Source Headline
20th Mar 201912:11 pmRNSHolding(s) in Company
19th Mar 20194:11 pmRNSDirector/PDMR Shareholding
14th Mar 20193:13 pmRNSHolding(s) in Company
14th Mar 20197:00 amRNSFinal Results
12th Mar 20194:46 pmRNSDirector/PDMR Shareholding
6th Mar 20196:03 pmRNSHolding(s) in Company
1st Mar 20197:00 amRNSTotal Voting Rights
25th Feb 20199:03 amRNSHolding(s) in Company
15th Feb 20197:00 amRNSBlock listing Interim Review
12th Feb 201912:48 pmRNSDirector/PDMR Shareholding
1st Feb 20197:00 amRNSTotal Voting Rights
21st Jan 201910:55 amRNSBlock listing Interim Review
15th Jan 20197:00 amRNSTrading Statement
14th Jan 20199:50 amRNSDirector/PDMR Shareholding
2nd Jan 20197:00 amRNSTotal Voting Rights
11th Dec 20183:07 pmRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSTotal Voting Rights
16th Nov 20182:44 pmRNSHolding(s) in Company
13th Nov 20182:46 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTotal Voting Rights
16th Oct 20183:13 pmRNSHolding(s) in Company
11th Oct 20183:26 pmRNSDirector/PDMR Shareholding
2nd Oct 201812:53 pmRNSDirector/PDMR Shareholding
1st Oct 20187:00 amRNSTotal Voting Rights
28th Sep 201812:28 pmRNSAcquisition
19th Sep 20189:34 amRNSDirectorate Change
18th Sep 20189:56 amRNSDirector/PDMR Shareholding
11th Sep 20181:58 pmRNSDirector/PDMR Shareholding
3rd Sep 20183:50 pmRNSTotal Voting Rights
15th Aug 20183:00 pmRNSBlock listing Interim Review
14th Aug 201811:00 amRNSDirector/PDMR Shareholding
13th Aug 201812:41 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSHalf-year Report
1st Aug 20187:00 amRNSTotal Voting Rights
26th Jul 201811:25 amRNSProposed Acquisition of Minority Interest
26th Jul 201811:19 amRNSAcquisition of Minority Interest
23rd Jul 20187:00 amRNSBlock listing Interim Review
16th Jul 201812:23 pmRNSDirector/PDMR Shareholding
15th Jun 20183:35 pmRNSDirector/PDMR Shareholding
14th Jun 201811:53 amRNSDirector/PDMR Shareholding
13th Jun 201812:00 pmRNSIssue of Equity
1st Jun 20187:00 amRNSTotal Voting Rights
14th May 201810:55 amRNSDirector/PDMR Shareholding
8th May 20184:37 pmRNSResult of AGM
8th May 201812:00 pmRNSAGM Statement
1st May 20187:00 amRNSTotal Voting Rights
26th Apr 20182:54 pmRNSDirector/PDMR Shareholding
25th Apr 20181:31 pmRNSDirector/PDMR Shareholding
18th Apr 201812:00 pmRNSIssue of Equity
17th Apr 201810:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.